| Particulars |
|
|
|
| Company Name
| Astrazeneca Pharma India Ltd
| Year End
| 202503
|
| Full Year |
| Equity (₹ Cr.) |
5.00 |
B.V. (₹) |
308.10 |
| Sales(₹ Cr.) |
1,716.29 |
NP (₹ Cr.) |
175.05 |
| NP Var% |
17.00 |
Div% |
0.00 |
| CPS(₹) |
86.00 |
EPS (₹) |
70.00 |
| Traded Value(₹ Lakhs) |
930.27 |
52 Week High |
10,023.00 |
| 52 Week Low |
5,635.00 |
Price BSE |
9,891.00 |
| Price NSE |
9,884.00 |
Market Capital (₹ Cr.) |
24,727.75 |
| P/C Ratio |
115.00 |
P/E Ratio |
141.30 |
| Price Vs.BV |
32.10 |
|
| Latest Quarter |
| Year End |
202503 |
Sales (₹ Cr.) |
480.48 |
| NP(₹ Cr.) |
62.27 |
NP Var % |
58.00 |
| Trailing Twelve Months |
| Year End |
202503 |
Sales |
1,484.51 |
| OPM |
13.09 |
NP |
128.73 |
| NP Var% |
17.44 |
EPS |
70.02 |
| PE |
141.26 |
|
|